An Observational Study On Metabolic Syndrome Parameters In Schizophrenia Patients Treated With Atypical Antipsychotics
- Conditions
- Metabolic Syndrome XSchizophrenia
- Interventions
- Other: No intervention
- Registration Number
- NCT00448630
- Lead Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Brief Summary
The purpose of the study is to find and follow-up the metabolic syndrome parameters on patients administering atypical antipsychotics.
- Detailed Description
Sampling Method Details: Group of patients using the same atypical anti-psychotic.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 328
- Female and male patients diagnosed as schizophrenia by the Diagnostic and Statistical Manual of Mental Disorders.
- Age between 18-45 years
- Patients who started atypical antipsychotic drug treatment or patients who switched from the previous conventional or atypical antipsychotic treatment to another atypical antipsychotic drug treatment by the decision of their physicians.
- Patients who are pregnant or considering pregnancy.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Atypical Antispychotics (or second generation antipsychotics) No intervention Patients with schizophrenia who are currently receiving or are going to start a new treatment with atypical antipsychotics, ziprasidone, risperidone, quetiapine, olanzapine, aripiprazole, amisulpride.
- Primary Outcome Measures
Name Time Method Metabolic Syndrome Parameter Waist Circumference Baseline, 1 Month, 4 Months Iterative measurement of waist circumference. Mean at timepoints.
Metabolic Syndrome Parameter Triglycerides Baseline, 1 Month, 4 Months Iterative measurement of triglycerides. Mean at time points
Metabolic Syndrome Parameter High Density Lipoprotein (HDL) Baseline, 1 Month, 4 Months Iterative measurement of HDL. Mean at time points
Metabolic Syndrome Parameter Fasting Blood Sugar Baseline, 1 Month, 4 Months Iterative measurement of fasting blood sugar. Mean at time points.
Metabolic Syndrome Parameter Body Weight Baseline, 1 Month, 4 Months Iterative measurement of body weight. Mean at time points.
Metabolic Syndrome Parameter Low Density Lipoprotein (LDL) Baseline, 1 Month, 4 Months Iterative measurement of LDL. Mean at time points
Metabolic Syndrome Parameter Body Mass Index (BMI) Baseline, 1 Month, 4 Months Iterative mean Body Mass Index at time points.
Metabolic Syndrome Parameter Total Cholesterol Baseline, 1 Month, 4 Months Iterative measurement of total cholesterol. Mean at time points.
- Secondary Outcome Measures
Name Time Method Metabolic Syndrome Parameter Weight by Treatment Group Baseline, 1 Month, 4 Months Iterative measurement of weight. Mean at time points.
Metabolic Syndrome Parameter Triglycerides by Treatment Group Baseline, 1 Month, 4 Months Iterative measurement of triglycerides. Mean at time points.
Metabolic Syndrome Parameter BMI by Treatment Group Baseline, 1 Month, 4 Months Iterative measurement of BMI. Mean at time points.
Metabolic Syndrome Parameter Waist Circumference by Treatment Group Baseline, 1 Month, 4 Months Iterative measurement of waist circumference. Mean at time points.
Trial Locations
- Locations (28)
Ankara Numune Research Hospital
🇹🇷Ankara, Turkey
Bolu Psychiatry and Neurology Hospital
🇹🇷Bolu, Turkey
Eskisehir Osmangazi University
🇹🇷Eskisehir, Turkey
Bakirkoy Mental Health Hospital, First Clinic of Neurosis
🇹🇷Istanbul, Turkey
Sisli Etfal Research and training Hospital
🇹🇷Istanbul, Turkey
Cukurova University Scool of Medicine
🇹🇷Adana, Turkey
Ankara Oncology Research and Training Hospital
🇹🇷Ankara, Turkey
Antakya Mustafa Kemal University School of Medicine
🇹🇷Antakya, Turkey
Bakirkoy Psychiatry and Neurology Hospital
🇹🇷Istanbul, Turkey
Marmara School of Medicine
🇹🇷Istanbul, Turkey
Ankara Numune Training and Research Hospital Department of Psychiatry
🇹🇷Ankara, Turkey
19 may University School of Medicine
🇹🇷Samsun, Turkey
Adana Psychiatry and Neurology Hospital
🇹🇷Adana, Turkey
Pfizer Investigational Site
🇹🇷Trakya, Turkey
Pamukkale University School Of Medicine
🇹🇷Denizli, Turkey
Elazig Mental Illness And Diseases Hospital
🇹🇷Elazig, Turkey
Cerrahpasa School of Medicine
🇹🇷Istanbul, Turkey
Istanbul University Istanbul School of Medicine
🇹🇷Istanbul, Turkey
Samsun Mental Illness And Diseases Hospital
🇹🇷Samsun, Turkey
Trakya University School of Medicine
🇹🇷Trakya, Turkey
Ankara Diskapi Training and Research Hospital
🇹🇷Ankara, Turkey
Erenkoy Psychology and neurology hospital
🇹🇷Istanbul, Turkey
Selcuk University Medical School Department of Psychiatry
🇹🇷Konya, Turkey
Manisa Mental Illness And Diseases Hospital
🇹🇷Manisa, Turkey
Vakif Gureba Hospital, Department of Psychiatry
🇹🇷Istanbul, Turkey
Ege University School Of Medicine
🇹🇷Izmir, Turkey
Kayseri Public Hospital
🇹🇷Kayseri, Turkey
Trabzon Numune Research Hospital
🇹🇷Trabzon, Turkey